US End-of-Day Verdict 5 Aug 2026, 16:00:00 GMT-4

Sector ETFs — End-of-Day Verdict

1 ACQUIRE, 0 DISPOSE. BUY 102 IBB @ at the 2026-08-07 open, stop, of (39.4%). Thirteen sessions of declines ended on the one name the book had already committed IN WRITING to buying at a specific unmet threshold: the 08-05 card recorded 'IBB re-arms on raw conviction >= 69' and today IBB printed raw 75, Buy_Rank 1, adj 71 after the live SE-1 -4 haircut -- clearing the 65 floor by six rather than missing it by one. THE GATE WAS NOT RELAXED, THE SETUP IMPROVED THROUGH IT. IBB is the only row on the board whose forward ladder ascends (Est_1W 193.21 / Est_4W 193.13 / Est_12W 203.03, all above the 192.97 entry, SE-2 does not fire) for a second straight session, at 4.00:1 against its stop, not extended (Entry_Distance_ATR 0.0), RSI 60.1, 3% below its 52W high. News CONFIRMS with a fund-flow basis rather than a headline: healthcare +11.2% over three months to a record vs the S&P's +6%, 44bn into US healthcare funds in July after 5bn in June reversing three months of outflows, biotech near one-year highs on decade-high M&A and 46 FDA approvals, at 24.4x forward earnings vs the market's 27.8x. The weakness is stated plainly: the 0.50-ATR stop sits under today's low in a family that stops out first 70% of the time, and it is the SAME construction that killed the 07-30 IBB card on its execution session. DECLINES: XLV (adj 71, TIES IBB and clears the floor) fails the arithmetic gate for a second session -- best forward +0.14% at 4wk against a 0.95% stop, Est_1W -0.24%, Est_12W -3.78% BELOW the entry, SE-2 fires; the same healthcare flows argue for it and cannot repair its own negative forward ladder. DIA (adj 62) falls below the floor for the first time in six sessions as the Dow gave back 388 points off its record on rising yields (claims 199k, July layoffs a two-year low); the gate fails independently. XLF is not a near-miss but a VINDICATION -- conviction 98 -> NO TRADE 0 in one session with Momentum flipping Bearish, so yesterday's withdrawal saved the book from owning a zero-rated position bought 0.6% above the current price. All four of the 08-05 ANTICIPATE names collapsed (XLK, DIA, XLI, SPY over three sessions) -- none repeated the print, so none could ever have reached 2-of-3, and the slot-eligibility rule was correct, not merely defensible. DXYZ was the day's biggest move (+5.61% on FTSE fast-tracking index entry ahead of the SpaceX IPO) and stays AVOID: it is the only priced row in the book and it reads OVERVALUED_VS_RI, MoS -0.78, Quality_Pass False, a closed-end fund at a large premium to NAV. DISPOSE: book is flat, nothing to trim or exit. Aug-6 tape: Dow -387.67 to 53,961.45 off its record, S&P -5.72 to 7,718.05, Nasdaq Composite +11.48 to 26,374.92; DXYZ +5.61%, XLE +1.48% (round-tripping yesterday's -2.07% on the same unresolved Hormuz story), XBI +0.97%, IBB +0.61% against SKYY -1.88%, XLI -0.85%, DIA -0.85%, AIQ -0.66%. : committed, remaining, self-financed.

Latest & archive All books

Recommendations

1 to acquire · 0 to dispose

Ticker	Name	Close	Action	Action Price Where to act — a buy-limit on a pullback or a buy-stop above resistance, not the current price. Sanity-check vs Close: on a held name, an action price stranded above the close means the queued level was set when the stock was higher — stale, awaiting reprice.	Stop The risk-defined exit, set below the entry for a long (~1.2–1.8×ATR). A held long whose Stop sits at/above the Close is already below its stop — a stale box awaiting reprice.	1wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close.	4wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close.	12wk Model estimate of the likely price at this horizon — a forward projection, not a guarantee, and separate from the trade's Action Price or Stop. Where the ML estimator is enabled these are per-ticker calibrated forecasts (~80% coverage band) that are refreshed periodically and can drift between refreshes; otherwise they're interpolated from the signal's swing target. Confirm against the settled close.	Rationale
IBB	iShares Biotech ETF	192.97	BUY	192.97	191.08	193.21 (+0.1%)	193.13 (+0.1%)	203.03 (+5.2%)	Buying biotech because the sector's money flows and its price chart have finally lined up at a price that is not already stretched. Healthcare has climbed 11.2% in three months to a record high while the wider market managed 6%, and roughly 50 US healthcare funds took in 44bn during July after 5bn in June -- reversing three straight months of withdrawals as investors rotate out of expensive AI-linked technology. Underneath that, biotech itself is cheaper than the market (24.4x forward earnings against 27.8x) with takeover activity at decade highs and 46 drug approvals last year. The fund is buyable at today's close rather than at a stretched price, sits 3% below its one-year high, and is the only holding on the board whose one-week, four-week and twelve-week forecasts each step higher than the last and all sit above the purchase price -- offering about four dollars of potential gain for every dollar risked. The honest caveat: the protective stop is tight enough that an ordinary quiet day could close the trade for about a 1% loss; the reward is a three-month story, the risk resolves within hours. OPS: BUY conv 75 (W42 -> W57 -> B68 -> B75), Buy_Rank 1, SE-1 live bias -4 -> adj 71, clears the 65 floor by 6. MEMORY TRIGGER FIRED: the 08-05 card recorded 'IBB re-arms on raw conviction >= 69' -- today raw = 75. Market entry, Entry_Distance_ATR 0.0, RSI 60.1, 3.05% below 52W high 199.05, above EMA20/50/200 and VWAP. SIZING: 49.24% x x 20% =, size_mod 1.0 (valuation blind), max_position_pct cap not binding, cap not binding -> = = 39.4% of declared. STOP = -0.98% = 0.50 ATR, sitting BELOW today's low 191.39 in the family whose stop_first_rate is 0.70 -- the identical construction that stopped the 07-30 IBB card out on its execution session. Accepted, not hidden: R:R = 7.55/1.89 = 4.00:1, the best on the board. GATE: clears at 12wk only (+5.21% vs a 0.98% stop = 5.3:1); Est_1W +0.12% and Est_4W +0.08% are flat. SE-2 does NOT fire (12wk 203.03 > 4wk 193.13 > close 192.97) -- the only such row on the board for a second session. Est_* read directly per ADR-0013 (~80% bands: 1W 188.79-199.02, 4W 183.56-209.37, 12W 175.27-231.16); calib_1w -0.068 degenerate so the 1wk figure carries a low-reliability flag per SE-3/L5. L8: execute at the 2026-08-07 open; NFP prints 8:30am ET pre-open -- REPRICE AND RE-VALIDATE if the open gaps >1.5% (outside -), do not fill blind. ADR-0019: the 07-30 IBB card (BUY 65 @189.96, stopped out) is STILL unrecorded, fifth session -- there are now two IBB cards a week apart and the older one has no outcome; record it TAKEN or SKIPPED. · news

Outcome & track record

Accuracy at the time of this record.

28 Graded decisions Past recommendations old enough to score against what actually happened (target hit / stopped out / closed). This is the evidence base — the bigger the number, the more history behind the calls. Click to inspect every one. See the decisions →

-0.068 1-week calibration How much of the eventual 4-week move typically shows up in the first week (0 = almost none, 1 = most of it). Use it to read the 1-week estimates: a low number means prices drift toward the target slowly, so don't over-read a soft week-1.

50 Published records How many dated end-of-day verdicts exist for this book — the length of the public track record you can browse in the Archive below.

Earlier record 5 August 2026 NO ACTION -- 0 ACQUIRE, 0 DISPOSE, 1 QUEUE WITHDRAWN. First session in twelve where every candidate fails for a reason the book can name in one line, and where the declines are not all one gate. XLF (adj 98, highest on the board) fails the ARITHMETIC GATE, not the floor: repriced to the buy-stop the live row prints, buys a new all-time high with a 3.56% / 3.00 ATR stop against forwards of -0.12% / +0.15% / -2.54%; fourth consecutive session of under-participation (+0.21% on a record Dow day) while the label printed 90, 100, 98. XLV (adj 73) clears the floor and fails on forecast + geometry: all three Est_* sit BELOW the entry (-0.29% / -0.29% / -3.85%) and the stop at is EXACTLY the session low, 0.53 ATR, in the family whose stop_first_rate is 0.70 -- LLY's +48% revenue quarter and XLV's record highs are real and do not repair that. IBB (adj 64) MISSES THE FLOOR BY ONE POINT and is the best-constructed row on the board -- the only clean ascending forward ladder (SE-2 does not fire), 4.00:1 vs its stop; the floor is a hard bar and is not waived for a good story, but it is armed at raw conviction >= 69. All four BUY - ANTICIPATE names (XLK 82/72, DIA 80/70, XLI 78/68, SPY 65/55) are SLOT-INELIGIBLE on the same rule -- each printed anticipation for the FIRST time today, where >=2 is required -- and all four independently fail the gate (XLK 9.59% stop vs +4.33%, DIA 4.11% vs +0.11%, XLI 5.08% vs +0.55%, SPY 4.10% vs -0.97%). DISPOSE: book is flat, nothing to trim or exit. Aug-5 tape was a clean defensive rotation -- Dow +0.49% to a record 54,349.12 while the Nasdaq snapped a 4-day rally (-0.83%), GLD +4.14% (the largest move on the board, printed NO TRADE cv0), XLV +1.27%, IBB +0.87%, XBI +0.74% against XLE -2.07%, SOXX -2.12% round-tripping yesterday's +6.80%, UFO -2.06%, QTUM -1.93%. Yesterday's own framing was confirmed rather than merely honest: 'if the limit does not fill there was nothing to make' -- it did not fill, and there was nothing to make. : committed, intact. Later record 7 August 2026 1 ACQUIRE + 1 QUEUED, 0 DISPOSE. BUY 217 XBI @ at the 2026-08-10 open, stop, of (68.3%); and QUEUE a GTC buy-limit 265 AIQ @, stop, expiring 2026-08-12. THE PENDING IBB ORDER DID NOT FILL AND THE GUARD IS WHY: July payrolls printed -23,000 against +80,000 expected, September hike odds fell from 55% to 40%, IBB opened at = +1.65% and OUTSIDE the card's -band, so the order was held for re-validation rather than filled blind. The honest cost is (a fill would have been at the open, not the close), and IBB's conviction then fell from below the floor -- the re-validation would have declined it anyway. THE BOOK BUYS THE SAME THESIS THROUGH A BETTER VEHICLE: XBI prints STRONG BUY conv 85, Buy_Rank 1, the only Mostly_Aligned row on the board, adj 81 after the live SE-1 -4 haircut -- 22 points above IBB. Its forward ladder ascends (Est_1W 157.56 / Est_4W 157.99 / Est_12W 162.29, all above the entry, SE-2 does not fire), it is not extended (Entry_Distance_ATR 0.0, RSI 60.2, 5% below its 52W high), and R:R is 3.41:1. NEWS CONFIRMS WITH A DATED MECHANISM: the NFP miss repriced the rate path, and biotech is the sector that responds most directly -- 'the rate-cut trade in disguise', currently the deepest pocket of Nasdaq leadership (~30% of leadership-screen stocks are biotech or healthcare), on decade-high M&A, 46 FDA approvals in 2025, at 24.4x forward vs the market's 27.8x. WEAKNESS STATED: the stop is exactly the session low, ninth such construction in nine sessions, in a family that stops out first 70% of the time; and the buy is a 30-point one-session flip out of AVOID -- fresh, not stable. DECLINES: GLD (adj 72, second-highest) broke out for real on gold +2.7% but risks 8.06% / 3.11 ATR for a +2.68% 12wk view = 0.33:1, and its buy-stop prints 1.55% BELOW the market; QQQ (adj 64) misses the floor by ONE point with otherwise the board's second-best geometry (3.77:1 at 12wk) and is armed at raw 69; XLK (adj 65) became the FIRST row in this book's history to satisfy the ADR-0012 anticipate-slot rule ( prints) and clear the floor, and was killed purely by geometry -- 8.41% / exactly 3.00 ATR of risk for a +3.31% 12wk best case and a NEGATIVE 1wk, in the 0-for-5 family; IWM (raw 83, the board's highest) is slot-ineligible at and risks 4.24% for +0.47%; XLI, UFO, IBB and MAGS are below the floor. SKYY is not a near-miss but a warning: the day's biggest gainer (+3.71%) printed ReversalDown_Overbought at conviction 86, RSI 72.9, AT its 52W high and +10.18% above VWAP -- the most extended row on the board, and long-only means no action. DISPOSE: nothing -- the book is flat, monitor clean, no stops to carry. THE LIVE THREAT TO BOTH CARDS IS THE SAME ONE: July CPI, Wednesday 2026-08-12, 8:30am ET, which decides whether Friday's rate repricing survives.